BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30160343)

  • 1. H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma.
    Chai D; Liu N; Li H; Wang G; Song J; Fang L; Lu Z; Yao H; Zheng J
    J Cell Mol Med; 2018 Nov; 22(11):5670-5681. PubMed ID: 30160343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8
    Chai D; Shan H; Wang G; Zhang Q; Li H; Fang L; Song J; Liu N; Zhang Q; Yao H; Zheng J
    Mol Cancer Ther; 2019 Feb; 18(2):323-334. PubMed ID: 30401695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absent in melanoma 2 enhances anti-tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer.
    Chai D; Qiu D; Zhang Z; Yuchen Shi S; Wang G; Fang L; Li H; Li H; Tian H; Zheng J
    J Cell Mol Med; 2020 Sep; 24(18):10744-10755. PubMed ID: 32725966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy induction.
    Chai D; Shan H; Wang G; Li H; Fang L; Song J; Zhang Q; Bai J; Zheng J
    Exp Cell Res; 2018 Sep; 370(2):561-570. PubMed ID: 30031129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma.
    Chai D; Zhang Z; Shi SY; Qiu D; Zhang C; Wang G; Fang L; Li H; Tian H; Li H; Zheng J
    Transl Oncol; 2021 Apr; 14(4):101018. PubMed ID: 33493800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma.
    Gao X; Jiang P; Zhang Q; Liu Q; Jiang S; Liu L; Guo M; Cheng Q; Zheng J; Yao H
    J Exp Clin Cancer Res; 2019 Aug; 38(1):362. PubMed ID: 31426831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.
    Yang Y; Zhang M; Jin C; Ding Y; Yang M; Wang R; Zhou Y; Zhou Y; Li T; Wang K; Hu R
    J Cell Biochem; 2019 Oct; 120(10):17744-17756. PubMed ID: 31210372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AIM2 Co-immunization with VP1 Is Associated with Increased Memory CD8 T Cells and Mounts Long Lasting Protection against Coxsackievirus B3 Challenge.
    Yin L; Chai D; Yue Y; Dong C; Xiong S
    Front Cell Infect Microbiol; 2017; 7():247. PubMed ID: 28642849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.
    Zhang M; Jin C; Yang Y; Wang K; Zhou Y; Zhou Y; Wang R; Li T; Hu R
    J Cell Physiol; 2019 Nov; 234(11):20161-20173. PubMed ID: 30953357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AIM2 co-immunization favors specific multifunctional CD8(+) T cell induction and ameliorates coxsackievirus B3-induced chronic myocarditis.
    Chai D; Yue Y; Xu W; Dong C; Xiong S
    Antiviral Res; 2015 Jul; 119():68-77. PubMed ID: 25956163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of absent in melanoma 2 in oral squamous cell carcinoma contributes to tumor progression.
    Nakamura Y; Nakahata S; Kondo Y; Izumi A; Yamamoto K; Ichikawa T; Tamura T; Noumi K; Yamashita Y; Morishita K
    Biochem Biophys Res Commun; 2019 Jan; 509(1):82-88. PubMed ID: 30587341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19/CCR7/AIM2 pathway.
    Zhou R; Sun J; He C; Huang C; Yu H
    Hum Cell; 2020 Oct; 33(4):1120-1132. PubMed ID: 32564199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment.
    Yu Q; Zhang M; Ying Q; Xie X; Yue S; Tong B; Wei Q; Bai Z; Ma L
    Cell Death Dis; 2019 Mar; 10(3):218. PubMed ID: 30833546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanidin Curtails Renal Cell Carcinoma Tumorigenesis.
    Liu X; Zhang D; Hao Y; Liu Q; Wu Y; Liu X; Luo J; Zhou T; Sun B; Luo X; Xu J; Wang Q; Yang Z; Li L
    Cell Physiol Biochem; 2018; 46(6):2517-2531. PubMed ID: 29742507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H1/pHGFK1 nanoparticles exert anti-tumoural and radiosensitising effects by inhibition of MET in glioblastoma.
    Zhang W; Duan R; Zhang J; Cheung WKC; Gao X; Zhang R; Zhang Q; Wei M; Wang G; Zhang Q; Mei PJ; Chen HL; Kung H; Lin MC; Shen Z; Zheng J; Zhang L; Yao H
    Br J Cancer; 2018 Feb; 118(4):522-533. PubMed ID: 29348487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis.
    Dawson RE; Deswaerte V; West AC; Tang K; West AJ; Balic JJ; Gearing LJ; Saad MI; Yu L; Wu Y; Bhathal PS; Kumar B; Chakrabarti JT; Zavros Y; Oshima H; Klinman DM; Oshima M; Tan P; Jenkins BJ
    Gut; 2022 Aug; 71(8):1515-1531. PubMed ID: 34489308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of the AIM2 molecule attenuates ischemia-reperfusion-induced spinal neuronal pyroptosis by inhibiting AIM2 inflammasome activation and subsequent release of cleaved caspase-1 and IL-1β.
    Li XQ; Yu Q; Fang B; Zhang ZL; Ma H
    Neuropharmacology; 2019 Dec; 160():107661. PubMed ID: 31181224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.
    Liu L; Xu Z; Zhong L; Wang H; Jiang S; Long Q; Xu J; Guo J
    BJU Int; 2016 Feb; 117(2):351-62. PubMed ID: 24612432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.